Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Authors

DOI:

https://doi.org/10.46570/utjms-2025-1397

Keywords:

MASLD, MASH, Pemafibrate, PPARS, Lipid profile, Liver fibrosis, Liver stiffness

Downloads

Published

2025-06-30

Issue

Section

Dr. Lance D. Dworkin Department of Medicine Research Symposium

How to Cite

1.
Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Translation. 2025;13(S3). doi:10.46570/utjms-2025-1397

Most read articles by the same author(s)

1 2 > >>